Filter Releases
 
Press Releases
Date Title and Summary View
Feb 8, 2013
CAMBRIDGE, MA--(Marketwire - Feb 8, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, a...
Jan 7, 2013
CAMBRIDGE, MA--(Marketwire - Jan 7, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, is providing an update regarding the progress of its Phase 3 study of BA058-Subcutaneous (SC). BA0...
Jan 3, 2013
CAMBRIDGE, MA--(Marketwire - Jan 3, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, completed enrollment for its randomized Phase 2 study of BA058-transdermal (BA058-TD) in healthy po...
Dec 20, 2012
Cambridge, Mass., December 20, 2012 – Radius Health, Inc. (“Radius”) and 3M Drug Delivery Systems are pleased to announce an exclusive partnership agreement for development and commercialization of BA058-transdermal (TD). BA058 is a novel, synthetic proprieta...
Nov 15, 2012
CAMBRIDGE, MA--(Marketwire - Nov 15, 2012) -  Radius Health, Inc. ("Radius"), announced today that it has voluntarily withdrawn its Registration Statement on Form S-1 (Registration No. 333-179397) (t...
Oct 12, 2012
CAMBRIDGE, MA--(Marketwire - Oct 12, 2012) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health...
Sep 27, 2012
Cambridge, MA, September 27, 2012 – Radius...
Jun 22, 2012
CAMBRIDGE, MA--(Marketwire - Jun 22, 2012) - Radius Health, a development-stage biopharmaceutical company focused on advanced therapies for healthy aging, will present scientific data from studies conducted with BA058 (a product candidate currently being developed for the treatment of postmenopausal osteoporosis) at ENDO 2012: The Endocrine Soc...
Apr 20, 2012
CAMBRIDGE, Mass., April  20, 2011—  Radius Health, Inc., a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, announcedtoday the appointment of Michael Franken as Senior Vice President and Chief Business Officer. Mr. Frank...
Feb 7, 2012
CAMBRIDGE, MA--(Marketwire - Feb 7, 2012) - Radius Health, Inc., a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, today announced that it has filed a registration statement with the Securities and Exchange Commission relating to a proposed public offering of...
= add release to Briefcase